Loading...
XCSE
NSIS B
Market cap27bUSD
Apr 02, Last price  
395.10DKK
Name

Novozymes A/S

Chart & Performance

D1W1MN
P/E
599.96
P/S
47.86
EPS
0.66
Div Yield, %
—
Shrs. gr., 5y
-0.61%
Rev. gr., 5y
-23.23%
Revenues
3.83b
-78.58%
6,281,000,0006,802,000,0007,438,000,0008,146,000,0008,448,000,0009,724,000,00010,510,000,00011,234,000,00011,746,000,00012,459,000,00014,002,000,00014,142,000,00014,531,000,00014,390,000,00014,374,000,00014,012,000,00014,951,000,00017,553,000,00017,899,000,0003,833,500,000
Net income
306m
-89.89%
861,000,000911,000,0001,042,000,0001,062,000,0001,194,000,0001,614,000,0001,828,000,0002,015,000,0002,200,000,0002,526,000,0002,823,000,0003,050,000,0003,119,000,0003,226,000,0003,154,000,0002,825,000,0003,146,000,0003,676,000,0003,024,000,000305,800,000
CFO
1.02b
-75.44%
1,326,000,0001,534,000,0001,714,000,0001,697,000,0001,817,000,0002,324,000,0002,709,000,0002,758,000,0002,599,000,0004,525,000,0003,339,000,0003,840,000,0004,063,000,0003,679,000,0003,196,000,0004,355,000,0004,062,000,0004,006,000,0004,152,000,0001,019,900,000
Dividend
Oct 11, 20234.2 DKK/sh
Earnings
May 01, 2025

Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
URL
https://www.novozymes.com/
IPO date
May 27, 1905
Employees
6,852
Domiciled in
DK
Incorporated in
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,833,500
-78.58%
17,899,000
1.97%
17,553,000
17.40%
Cost of revenue
3,202,700
13,518,000
13,200,000
Unusual Expense (Income)
NOPBT
630,800
4,381,000
4,353,000
NOPBT Margin
16.45%
24.48%
24.80%
Operating Taxes
111,300
870,000
870,000
Tax Rate
17.64%
19.86%
19.99%
NOPAT
519,500
3,511,000
3,483,000
Net income
305,800
-89.89%
3,024,000
-17.74%
3,676,000
16.85%
Dividends
(249,800)
(2,856,000)
(1,524,000)
Dividend yield
Proceeds from repurchase of equity
37,800
167,000
(336,000)
BB yield
Debt
Debt current
266,400
3,173,000
123,000
Long-term debt
1,530,400
4,929,000
699,000
Deferred revenue
105,300
129,000
Other long-term liabilities
39,700
2,218,000
4,722,000
Net debt
1,474,100
6,741,000
(534,000)
Cash flow
Cash from operating activities
1,019,900
4,152,000
4,006,000
CAPEX
(338,300)
(1,857,000)
(2,890,000)
Cash from investing activities
(199,700)
(2,133,000)
(2,672,000)
Cash from financing activities
(703,200)
(1,889,000)
(1,250,000)
FCF
13,441,800
4,283,000
(1,715,000)
Balance
Cash
284,000
1,156,000
1,121,000
Long term investments
38,700
205,000
235,000
Excess cash
131,025
466,050
478,350
Stockholders' equity
11,158,000
15,029,000
14,228,000
Invested Capital
12,986,775
23,835,950
18,685,650
ROIC
2.82%
16.51%
19.46%
ROCE
4.39%
18.03%
20.91%
EV
Common stock shares outstanding
277,900
277,875
278,734
Price
Market cap
EV
EBITDA
630,800
5,770,000
5,810,000
EV/EBITDA
Interest
173,000
102,000
Interest/NOPBT
3.95%
2.34%